GYNETHOTICS
LIVE

Serial Number

98033399

Owner

COSM Medical Corp.

Attorney

Lisa Adams

Filing Date

Jun 8, 2023

Add to watchlist:

No watchlists yet
View on USPTO

GYNETHOTICS Trademark

Serial Number: 98033399

GYNETHOTICS is a trademark filed by COSM Medical Corp. on June 8, 2023. The trademark is classified under Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

COSM Medical Corp. (2 trademarks)

410 - 1001 Roselawn Ave
Toronto ON M6B4M4 , CA

Entity Type: 03

Trademark Details

Filing Date

June 8, 2023

Registration Date

Not Registered

Goods & Services

Medical devices for preventing female stress urinary incontinence, urinary incontinence and prolapse of pelvic organs; medical devices for treating and diagnosing urinary incontinence and prolapse of pelvic organs; medical devices, namely, pessaries for managing symptoms of female stress urinary incontinence, urinary incontinence and prolapse of pelvic organs; medical intra-vaginal devices, namely, pessaries for therapeutic purposes; medical devices for intervaginal use, namely, infusion and injection devices and syringes for administering pharmaceutical agents, namely, hormones, spermicides, proteins, and regenerative medicines; gynecological medical instruments for examining women's reproductive organs; gynecological medical devices for dimensional measurement of a women's reproductive organs, namely, 3D scanner for human body

Providing on-line non-downloadable software for monitoring implanted medical devices, including implanted medical prostheses, for preventing female stress urinary incontinence, urinary incontinence and prolapse of pelvic organs

Leasing and rental of user-specific medical devices for preventing female stress urinary incontinence, urinary incontinence and prolapse of pelvic organs; leasing and rental of user- specific medical devices for treating and diagnosing urinary incontinence and prolapse of pelvic organs; leasing and rental of user-specific medical devices, namely, pessaries for managing symptoms of female stress urinary incontinence, urinary incontinence and prolapse of pelvic organs; leasing and rental of user-specific medical devices for inter-vaginal use in administering pharmaceutical agents, namely, hormones, spermicides, proteins, and regenerative medicines; providing a website featuring medical information about medical devices for preventing urinary incontinence and prolapse of pelvic organs; providing a website featuring medical information about gynecological medical instruments for examining and measuring a women's reproductive organs; providing on-line medical information about medical devices for preventing urinary incontinence and prolapse of pelvic organs; providing on-line medical information about gynecological medical instruments for examining and measuring a women's reproductive organs

Retail and online retail shop services featuring user-specific medical devices for preventing female stress urinary incontinence, urinary incontinence and prolapse of pelvic organs; retail store services featuring user-specific medical devices for treating and diagnosing urinary incontinence and prolapse of pelvic organs; retail store services featuring user-specific medical devices, namely, pessaries for managing symptoms of female stress urinary incontinence, urinary incontinence and prolapse of pelvic organs; retail store services featuring user-specific medical devices for inter-vaginal use in administering pharmaceutical agents, namely, hormones, spermicides, proteins, and regenerative medicines; providing a website featuring consumer product information about medical devices for preventing urinary incontinence and prolapse of pelvic organs; providing a website featuring consumer product information about gynecological medical instruments for examining and measuring a women's reproductive organs; providing on-line consumer product information about medical devices for preventing urinary incontinence and prolapse of pelvic organs; providing on-line consumer product information about gynecological medical instruments for examining and measuring a women's reproductive organs

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 30, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 30, 2026 GNSL
SUSPENSION LETTER WRITTEN
Apr 30, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 20, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 20, 2026 CRFA
ASSIGNED TO LIE
Apr 20, 2026 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 15, 2026 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 16, 2026 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 16, 2026 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 16, 2026 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 18, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 17, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
May 17, 2025 GNSL
SUSPENSION LETTER WRITTEN
May 17, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 14, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 14, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 14, 2025 ERSI
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 13, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 13, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 13, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 13, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 13, 2025 COAR
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Feb 14, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Feb 14, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Feb 14, 2025 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 10, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 22, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 22, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jul 22, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 31, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 31, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 31, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 1, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 1, 2024 GNRT
NON-FINAL ACTION WRITTEN
Mar 1, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 28, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 12, 2023 NWOS
NEW APPLICATION ENTERED
Jun 12, 2023 NWAP